Related references
Note: Only part of the references are listed.DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β
Xiao-Fang Liu et al.
CELL DEATH & DISEASE (2018)
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Linda Yang et al.
NATURE MEDICINE (2017)
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Shannon E. Mullican et al.
NATURE MEDICINE (2017)
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Paul J. Emmerson et al.
NATURE MEDICINE (2017)
Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways
B. Xin et al.
ONCOGENE (2017)
LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer
Hao-Zhe Cao et al.
CELL DEATH & DISEASE (2017)
Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality
Raaj S. Mehta et al.
GASTROENTEROLOGY (2015)
GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma
C. Z. Yang et al.
ANNALS OF ONCOLOGY (2014)
Transforming growth factor-β (TGF-β) induces the expression of chondrogenesis-related genes through TGF-β receptor II (TGFRII)-AKT-mTOR signaling in primary cultured mouse precartilaginous stem cells
Li Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
Xiaobing Wang et al.
BMC CANCER (2014)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion
Samantha E. Griner et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
Klaus Unsicker et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Endoglin inhibits ERK-induced c-Myc and cyclin D1 expression to impede endothelial cell proliferation
Christopher C. Pan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Kruppel-like factor 4 functions as a tumor suppressor in cervical carcinoma
Wen-Ting Yang et al.
CANCER (2012)
Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways
Young-June Jin et al.
CELLULAR SIGNALLING (2012)
Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
Ke-Hung Tsui et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells
Jayashree P. Joshi et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
U. Wallin et al.
BRITISH JOURNAL OF CANCER (2011)
Pancreatic Tumor Suppression by Benzyl Isothiocyanate Is Associated with Inhibition of PI3K/AKT/FOXO Pathway
Srinivas Reddy Boreddy et al.
CLINICAL CANCER RESEARCH (2011)
Feedback regulation of EGFR signalling: decision making by early and delayed loops
Roi Avraham et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Divergent Molecular Mechanisms Underlying the Pleiotropic Functions of Macrophage Inhibitory Cytokine-1 in Cancer
Murielle Mimeault et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
Macrophage Inhibitory Cytokine-1 Is Overexpressed in Malignant Melanoma and Is Associated with Tumorigenicity
Glen M. Boyle et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells
Kwang-Kyu Kim et al.
CARCINOGENESIS (2008)
Gene expression changes during HPV-mediated carcinogenesis:: A comparison between an in vitro cell model and cervical cancer
Fang Wan et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Arginine Methylation of FOXO Transcription Factors Inhibits Their Phosphorylation by Akt
Kazuyuki Yamagata et al.
MOLECULAR CELL (2008)
Nuclear receptor hepatocyte nuclear factor 4 alpha 1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter
Wendy W. Hwang-Verslues et al.
MOLECULAR ENDOCRINOLOGY (2008)
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins
Mako Narisawa-Saito et al.
CANCER SCIENCE (2007)
Dynamic FoxO transcription factors
Haojie Huang et al.
JOURNAL OF CELL SCIENCE (2007)
Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells
Siu-Ju Chen et al.
PROSTATE (2007)
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
JB Welsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer
M Zajac-Kaye
LUNG CANCER (2001)
Share Paper
